Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$3.91 USD
+0.07 (1.82%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $3.90 -0.01 (-0.26%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Myriad Genetics, Inc. has a market cap of $353.96M, which represents its share price of $3.84 multiplied by its outstanding shares number of 92.18M. As a small-cap company, MYGN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MYGN 3.91 +0.07(1.82%)
Will MYGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MYGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MYGN
Tempus AI Boosts R&D Efforts Through Wide-Ranging Product Launches
Should You Hold Myriad Genetics Stock in Your Portfolio Right Now?
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?
Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue?
Down -49.47% in 4 Weeks, Here's Why Myriad (MYGN) Looks Ripe for a Turnaround
Other News for MYGN
Myriad Genetics (MYGN) Secures $200 Million Loan Facility from OrbiMed
Myriad genetics announces new $200 million credit facility
Myriad Genetics Announces New $200 Million Credit Facility | MYGN Stock News
Myriad Genetics announces $200M credit facility